• Richards Group's third-quarter 2026 gross margins rose on a stronger healthcare mix.
• Revenue increased, driven by contributions from the PharmaSystems acquisition.
• Organic Healthcare revenue rose on consumables and low-price capital equipment, while Packaging revenue fell, reflecting the macro environment.
• The group refinanced bank debt to 2030, increasing availability to $150 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Richards Group Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202610291900NEWSFILECNPR____20261029_321679_1) on October 29, 2026, and is solely responsible for the information contained therein.